None listed
Conditions
Brief summary
The aim of the study is to compare the effectivity of two methods of lowering central venous pressure (CVP) on the ease to reach the predefined target of CVP lower than 5 mmHg. Patients´ postoperative outcome assessed via composite morbidity (complications rate) and mortality till 30 days and hospital length of stay as well as intraoperative safety outcomes (hemodynamic stability, markers of global oxygen debt, blood loss,) will be assessed, allowing to define simple, standardized and safe approach of low-CVP anesthesia.
Interventions
Comparison of two strategies of reaching low central venous pressure (Low-CVP; below 5 mmHg) during liver resection surgery. One strategy is using absolute fluid restriction (Arm 1 - intervention), the other one relative volume redistribution caused by systemic vasodilation (Arm 2 - control). Treatments in both groups will be administered by treating anaesthesiologist (member of the study team) according to the randomization during the preoperative (from morning till surgery) and intraoperative period. Treatments in both arms will be graded into predefined steps. In the Arm 1 absolute restriction of circulating volume will be provided by reduction of preoperative fluids (neither intravenous nor oral intake 6 hours prior surgery) coupled with minimal (1ml/kg/hour, Ringerfundin solution - B´Braun) intraoperative intravenous supplementation. If needed, given the CVP value assessed by the treating anaesthesiologist, diuretics will be further administered (Furosemide 10mg intravenous per step, maximum 3 doses allowed i.e. up to three steps) to reach the low-CVP target. Participants will receive only the minimal number of steps required to reach the 5mmHg CVP target.
Sponsors
Study design
Eligibility
Inclusion criteria
patients scheduled for hepatic resection of more than 2 liver segments, general anesthesia, regullar heart rhythm, signed informed consent
Exclusion criteria
body weight less than 50 kg or more than 150 kg, irregular heart rythm, severe cardiovascular disease (chronic heart failure, valvular abnormality, cardiomyopathy etc.), severe liver dysfunction (Child Pugh score B or C)